peroxisome proliferatoractivated receptor gamma pparγ pparg also known glitazone reverse insulin resistance receptor nuclear receptor subfamily group c member type ii nuclear receptor functioning transcription factor humans encoded pparg pparg mainly present adipose tissue colon macrophages two isoforms pparg detected human mouse found nearly tissues except muscle mostly found adipose tissue gene encodes member peroxisome proliferatoractivated receptor ppar subfamily nuclear receptors ppars form heterodimers retinoid x receptors rxrs heterodimers regulate transcription various genes three subtypes ppars known pparalpha ppardelta ppargamma protein encoded gene ppargamma regulator adipocyte differentiation alternatively spliced transcript variants encode different isoforms activity pparg regulated via phosphorylation mekerk pathway modification decreases transcriptional activity pparg leads diabetic gene modifications results insulin insensitivity example phosphorylation serine inhibit pparg function enhance adipogenic potential pparg regulates fatty acid storage glucose metabolism genes activated pparg stimulate lipid uptake adipogenesis fat cells pparg knockout mice devoid adipose tissue establishing pparg master regulator adipocyte pparg increases insulin sensitivity enhancing storage fatty acids fat cells reducing lipotoxicity enhancing adiponectin release fat cells inducing enhancing nicotinic acid adenine dinucleotide phosphate production upregulation pparg promotes antiinflammatory macrophage activation adiponectin induces reverse cholesterol transport activation pparγ many naturally occurring agents directly bind activate ppar gamma agents include various polyunsaturated fatty acids like arachidonic acid arachidonic acid metabolites certain members acid family eg acid family including phytocannabinoid tetrahydrocannabinol metabolite thccooh synthetic analog ajulemic acid activation ppar gamma ligands may responsible inhibiting growth cultured human breast gastric lung prostate cancer cell embryogenesis pparg first substantially expresses interscapular brown fat depletion pparg result embryonic lethality due vascular anomalies placenta permeation fetal blood vessels dilation rupture maternal blood expression pparg detected placenta early remainder gestation mainly located primary trophoblast cell human pparg required epithelial differentiation trophoblast tissue critical proper placenta vascularization pparg agonists inhibit extravillous cytotrophoblast invasion pparg also required accumulation lipid droplets peroxisome proliferatoractivated receptor gamma shown interact ppargamma agonists used treatment hyperlipidaemia many insulin sensitizing drugs namely thiazolidinediones used treatment diabetes activate pparg means lower serum glucose without increasing pancreatic insulin secretion activation pparg effective skeletal muscle insulin resistance insulin resistance article incorporates text united states national library medicine public domain angstrom resolution crystal structure heterodimer human rxralpha ppargamma ligand binding domains respectively bound retinoic acid rosiglitazone coactivator peptides angstrom resolution crystal structure heterodimer human rxralpha ppargamma ligand binding domains respectively bound retinoic acid coactivator peptides crystal structure ligand binding domain human ppargamma complex agonist az angstrom resolution crystal structure heterodimer human ppargamma rxralpha ligand binding domains respectively bound retinoic acid coactivator peptides ligand binding domain human peroxisome proliferator activated receptor gamma complex synthetic agonist ligand binding domain human peroxisome proliferator activated receptor gamma complex agonist ligand binding domain human peroxisome proliferator activated receptor gamma crystal structure new rexinoid bound rxralpha ligand binding doamin rxralphappargamma heterodimer ppargamma complex compound crystal structure human ppargamma ligand binding domain complexed alphaaryloxyphenylacetic acid agonist structural biochemical basis selective repression orphan nuclear receptor shp crystal structure ligand binding domain human ppargamma im complex agonist crystal structure ligand binding domain human ppargamma complex agonist novel antiadipogenic partial agonist peroxisome proliferatoractivated receptorgamma pparg recruits alpha potentiates insulin signaling vitro structurebased drug design novel family ppar partial agonists virtual screening xray crystallography vitroin vivo biological activities structurebased drug design novel family ppar partial agonists virtual screening xray crystallography vitroin vivo biological activities structurebased design indole propionic acids novel pparag coagonists crystal structure ppar gamma carboxamide ligands crystal structure complex ppargamma agonist ureidofibrate derivative crystal structure complex ppargamma partial agonist ureidofibrate derivative structure obtained crystals apoform soaked days crystal structure complex ppargamma partial agonist ureidofibrate derivative structure obtained crystals soaked hours ajulemic acid synthetic cannabinoid bound ppar gamma ligandbinding domain human peroxisome proliferator activated receptor gamma ligand binding domain human peroxisome proliferator activated receptor partial agonist ppar gamma cocrystal httpsenwikipediaorgwikiperoxisomeproliferatoractivatedreceptorgamma